
Sustainable competitive advantage requires combining proprietary evidence, AI, and human expertise—not substituting one for another.
Ten life sciences board directors on AI's three hardest questions: developing the next generation of talent, accountability for speed, and board fluency.
This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industry rarely produces: an off-the-record conversation about AI with no agenda beyond the conversation itself.





